The pathophysiology of the insulin‐like growth factor axis in fetal growth failure: a basis for programming by undernutrition?
- 1 December 1994
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 24 (12) , 851-856
- https://doi.org/10.1111/j.1365-2362.1994.tb02030.x
Abstract
Recent evidence suggests that a number of adulthood conditions, including non‐insulin dependent diabetes mellitus (NIDDM) and lipid and cardiovascular abnormalities are associated with intra‐uterine growth retardation (IUGR). It is possible that this arises from programming of endocrine axes during development as a result of an adverse intra‐uterine environment. Insulin‐like growth factors (IGFs) are mitogenic polypeptides which stimulate cellular proliferation and differentiation and are important in human fetal development. The functions of IGFs are modulated by specific high affinity binding proteins (IGFBPs). IGFBP‐1 is antagonistic to the insulin‐like and growth promoting effects of IGF‐I, and IGFBP‐3 holds IGFs in the circulation by associating with IGFs and an acid labile subunit to form a ternary complex. Using specific radioimmunoassays and fetal serum obtained during diagnostic cordocentesis we have investigated the role of the IGF/IGFBP axis in human fetal development. In a study of 130 singleton pregnancies we have examined levels of immunoreactive IGFs and IGFBPs in normally grown fetuses (AGA), starved small fetuses affected by uteroplacental insufficiency (UPI), and non‐starved small fetuses (SGA). IGF‐1 was significantly lower in the UPI group (n= 14, 7·8±0·6 μg l‐1), than in either the SGA group (n= 22, 31·4±3·5 μg l‐1, P= 0·0001) or the AGA group (n= 94, 36·3±1·9 μg l‐1, P= 0·0001). IGFBP‐3 showed similar changes (UPI: 682·6±50·0 μg l‐1; SGA: 831·9±55·5 μg l‐1; AGA: 847·7±19·8 μg l‐1). In contrast, IGFBP‐1 levels were significantly higher in the UPI group (312·4±57·5 μg l‐1) than in either the SGA group (132·6±39·5 μg l‐1, P= 0·009) or the AGA group (116·9±25·4 μg l‐1, P= 0·003), and the normal inverse relationship between IGFBP‐1 and insulin levels was lost in the UPI group. IGFBP‐2 levels showed a similar pattern (UPI: 2510·3±178·0 μg l‐1; SGA: 878·5±80·3μg l‐1, P= 0·0001; AGA: 791·6±27·0 μg l‐1, P= 0·0001). Thus, there are clear differences between the two groups of SGA fetuses. It is possible that in utero‘programming’ of the IGF/IGFBP axis, as a result of fetal undernutrition, may be important in the pathogenesis of disease in adulthood.Keywords
This publication has 41 references indexed in Scilit:
- Response of insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) and IGFBP-3 to IGF-I treatment in severe insulin resistanceJournal of Endocrinology, 1994
- Role of insulin-like growth factors in embryonic and postnatal growthCell, 1993
- Role of insulin-like growth factors in embryonic and postnatal growthCell, 1993
- Intrauterine growth retardation: future research directionsActa Paediatrica, 1993
- The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteersJournal of Endocrinology, 1993
- Metabolic and endocrine findings in appropriate and small for gestational age fetusesjpme, 1991
- Insulin‐Like Growth Factor (IGF) Binding Proteins: the Role of Serum IGFBPs in Regulating IGF AvailabilityActa Paediatrica, 1991
- Binding proteins for the insulin-like growth factors: Structure, regulation and functionProgress in Growth Factor Research, 1989
- A Longitudinal Study on Plasma Somatomedin Activity in Full-Term, Preterm and Small-for-Gestational Age NewbornsNeonatology, 1981
- Low somatomedin activity in cord serum from infants with intrauterine growth retardationThe Journal of Pediatrics, 1980